A voice to help shape the future of healthcare

Strongly invested in improving diabetes care and monitoring, the Juvenile Diabetes Foundation of Chile supports Colive Voice

• Colive Voice
• Department of Precision Health
• Deep Digital Phenotyping Research Unit

Colive Voice, an international digital health study led by the Luxembourg Institute of Health’s Deep Digital Phenotyping research unit, aims to identify vocal biomarkers for chronic diseases, such as diabetes and cancer. Owing to the significant opportunities for improvement in diabetes monitoring, the Juvenile Diabetes Foundation of Chile has agreed to join the project and raise awareness about the study in Chile.

Created to fill the gap in information and support regarding diabetes by a group of parents with children affected by this disease, the Foundation’s main mission is to welcome, support and educate people living with type 1 diabetes, as well as their relatives. The association sets up awareness campaigns in order to help affected people improve their understanding of diabetes, as well as its treatment options and adherence. It relies on a team of specialized health professionals and educators to organize activities, workshops and conferences for children, adolescents and their parents. 

Through the partnership, the Foundation is committed to raising awareness of the Colive Voice project among its members and supporting the recruitment of new participants with diabetes. The Foundation has already communicated about the project through messages on their social media channels, as well as webinars dedicated to diabetes and new technologies or workshops. This support is essential in order to include a maximum number of people living with diabetes in the study and to identify relevant vocal biomarkers for the screening and monitoring of this disease.

The identified vocal biomarkers could lead to concrete applications for diabetes screening and monitoring, for example by integrating voice-based monitoring into digital health applications or telemedicine solutions. Improving the detection and management of diabetes symptoms (hypo/hyperglycemia, diabetes distress, fatigue…) would simplify screening and improve the quality of life of millions of people with diabetes worldwide.

The support of the Juvenile Diabetes Foundation of Chile is essential for the international recruitment of Colive Voice participants. The actions put in place by our partner will allow us to recruit enough participants with relevant profiles for our project, to move forward on the identification of key vocal biomarkers that will help us develop new screening and monitoring tools for diabetes. We are extremely grateful for their collaboration.

comments Dr. Guy Fagherazzi, Director of Precision Health Unit and principal investigator of Colive Voice.

ABOUT THE JUVENILE DIABETES FOUNDATION OF CHILE

Created in 1988 by a group of parents of children with diabetes, the Juvenile Diabetes Foundation of Chile’s main objective is to help all people affected by this disease. The Foundation offers its members workshops for different age groups, such as cooking workshops, workshops on carbohydrate calculation, workshops for teenagers or parents, conferences on diabetes and many others.

It also organizes camps, a real “outdoor school”, which brings together children and teenagers with type 1 diabetes mellitus (DM1) to help them discover treatments, encourage them to take care of themselves and persevere in their treatment. Finally, in order to facilitate access to treatment, the Foundation has launched her own pharmacy.

Visit our partner website

Colive Voice is an international digital health research initiative that aims to improve diagnosis and monitoring of various chronic conditions (like diabetes, cancer, COVID-19) by evaluating voice features known as vocal biomarkers. This innovative study is led by the Deep Digital Phenotyping (DDP), a research unit of the Luxembourg Institute of Health. Participation is open to all adults and adolescents above 15 years of age regardless of their health status, and is done anonymously via a secure web application. Colive Voice is accessible from a smartphone, tablet, or laptop equipped with a microphone.

To participate, or for more information, visit https://www.colivevoice.org

The Luxembourg Institute of Health (LIH) is a public biomedical research organization focused on precision health and invested in becoming a leading reference in Europe for the translation of scientific excellence into meaningful benefits for patients.

LIH places the patient at the heart of all its activities, driven by a collective obligation towards society to use knowledge and technology arising from research on patient derived data to have a direct impact on people’s health. Its dedicated teams of multidisciplinary researchers strive for excellence, generating relevant knowledge linked to immune related diseases and cancer.

The institute embraces collaborations, disruptive technology and process innovation as unique opportunities to improve the application of diagnostics and therapeutics with the long-term goal of preventing disease.